Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
TBPH —
THERAVANCE BIOPHARMA INC
CUSIP: G8807B106 · Held by 1 superinvestor · Combined value: $4,409,947
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $4,409,947 | 235,700 | ADD | +184,833 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +184,833 | +363.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | REDUCE | -434,464 | -89.5% |
Who Owns TBPH? Superinvestor Holdings
THERAVANCE BIOPHARMA INC is held by 1 tracked superinvestor, with a combined position value of $4 million . The largest positions are held by Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions.